Inventor · disambiguated record
Heon Jong Lee
Also filed as: LEE HEON JONG
10 granted patents·8 pending applications·12 citations·filing 2017–2024
82Inventor score
Top patents by PatentIndex Score
18 records- 0193US11433114B2Composition for cell protection containing cyclo histidine-proline as active ingredientNOVMETAPHARMA CO LTD·Filed 2021·Granted Sep 6, 2022·3 cites·18 claims
- 0287US10792280B2Pharmaceutical composition comprising amodiaquine and anti-diabetes drug as effective ingredient for prevention or treatment of diabetesNOVMETAPHARMA CO LTD·Filed 2017·Granted Oct 6, 2020·5 cites·8 claims
- 0377US11975041B2Composition comprising CHP (cyclo-his pro) for preventing, improving or treating of bone loss related diseaseNOVMETAPHARMA CO LTD·Filed 2018·Granted May 7, 2024·1 cites·13 claims
- 0476US11607441B2Pharmaceutical composition for preventing or treating diabetes, containing zinc salt, cyclo-hispro and antidiabetic drug as active ingredientsNOVMETAPHARMA CO LTD·Filed 2018·Granted Mar 21, 2023·1 cites·6 claims
- 0576US10918693B2Composition for cell protection containing cyclo histidine-proline as active ingredientNOVMETAPHARMA CO LTD·Filed 2017·Granted Feb 16, 2021·2 cites·13 claims
- 0675US11890317B2Cell-protecting composition containing cyclo histidine-proline as active ingredientNOVMETAPHARMA CO LTD·Filed 2022·Granted Feb 6, 2024·0 cites·14 claims
- 0770US2024082240A1Method for treatment of cytokine release syndromeNOVMETAPHARMA CO LTD·Filed 2023·Application pending·0 cites
- 0867US2025161301A1Composition for preventing, ameliorating or treating obesity and diabetes comprising zinc gluconate and cyclo-hispro as active ingredientsNOVMETAPHARMA CO LTD·Filed 2024·Application pending·0 cites
- 0965US11850246B2Method for treatment of cytokine release syndromeNOVMETAPHARMA CO LTD·Filed 2021·Granted Dec 26, 2023·0 cites·9 claims
- 1062US2024140955A1Peg-modified cyclic dipeptidesNOVMETAPHARMA CO LTD·Filed 2023·Application pending·0 cites
- 1158US12496309B2Method for treatment of pancreatitisNOVMETAPHARMA CO LTD·Filed 2022·Granted Dec 16, 2025·0 cites·8 claims
- 1257US2022218793A1Use of composition for preventing, ameliorating, or treating bone loss disorders, comprising cyclo-hispro (chp) and parathyroid hormoneNOVMETAPHARMA CO LTD·Filed 2020·Application pending·0 cites
- 1356US2024261366A1Treatment of beta-cell failure or dysfunctionNOVMETAPHARMA CO LTD·Filed 2024·Application pending·0 cites
- 1454US12053467B2Method of treating fibrosisNOVMETA PHARMA CO LTD·Filed 2020·Granted Aug 6, 2024·0 cites·13 claims
- 1552US11413270B2Method for the treatment of pancreatitisNOVMETAPHARMA CO LTD·Filed 2020·Granted Aug 16, 2022·0 cites·7 claims
- 1650US2023165855A1Use of cyclo-hispro (chp) for lowering blood pressureNOVMETAPHARMA CO LTD·Filed 2021·Application pending·0 cites
- 1744US2021401880A1Pharmaceutical Composition For Preventing Or Treating Obesity, Containing CYCLO(HIS-PRO) As Active IngredientNOVMETAPHARMA CO LTD·Filed 2019·Application pending·0 cites
- 1842US2021100872A1Pharmacological Formulation Comprising Cyclo (HIS-PRO) As Effective Ingredient For Preventing Or Treating Diabetes MellitusNOVMETAPHARMA CO LTD·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Heon Jong Lee files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →